Terano A, Arakawa T, Sugiyama T. Rebamipide, a gastro-protective and anti-inflammatory drug, promotes gastric ulcer healing following eradication therapy for Helicobacter pylori in a Japanese population: a randomized, doubleblind, placebo-controlled trial.. J Gastroenterol, 2007, 42: 690-693.
Han X, Jiang K, Wang B. Effect of Rebamipide on the Premalignant Progression of Chronic Gastritis: A Randomized Controlled Study. Clin Drug Investig, 2015 Oct, 35(10): 665- 73.
Endo H, Hosono K, Inamori M. Characteristics of small bowel injury in symptomatic chronic low-dose aspirin users: the experience of two medical centers in capsule endoscopy. J Gastroenterol, 2009, 44: 544-549.
Endo H, Higurashi T, Hosono K. Efficacy of Lactobacillus casei treatment on small bowel injury in chronic low-dose aspirin users: a pilot randomized controlled study .J Gastroenterol, 2011, 46: 894-905.
Fellows IW, Clarke JMF, Roberts PF. Nonsteroidal anti-inflammatory drug-induced jejunal and colonic diaphragm disease: a report oftwo cases. Gut, 1992, 33: 1424-1426.
Tozawa K, Oshima T, Okugawa T. A Randomized, Double-Blind, Placebo-Controlled Study of Rebamipide for Gastric Mucosal Injury Taking Aspirin With or Without Clopidogrel. Dig. Dis. Sci., 2014, 59: 1885-1890.
Mizukami K, Murakami K, Abe T. Aspirininduced small bowel injuries and the preventive effect of rebamipide. World J Gastroenterol, 2011 December 14, 17(46): 5117-5122.
Kyung Hwa Lee, Jee-Yeon Kim. Protective Effect of Rebamipide Against Helicobacter pylori- CagA-Induced Effects on Gastric Epithelial Cells. Dig. Dis. Sci.. 2011, 56: 441-448.
Masahiro Hasegawa , Noriyuki Horiki. Theefficacy of rebamipide add-on therapy in arthritic patients with COX-2 selective inhibitor- related gastrointestinal events: a prospective, randomized, open-label blinded-endpoint pilot study by the GLORIA study group. Mod Rheumatol, 2013, 23: 1172-1178.
Takayama M, Matsui Sh. Efficacy of treatment with rebamipide for endoscopic submucosal dissection-induced ulcer. World J Gastroenterol, 2013 September 14, 19(34): 5706-5712.
Koyama N, Sasabe H and Miyamoto G. Involvement of cytochrome P450 in the metabolism of rebamipide by the human liver. Xenobiotica, 2002, 327
Genta RM. Review article: the role of rebamipide in the management of inflammatory disease of the gastrointestinal tract. Aliment Pharmacol Ther, 2003, 18(Suppl. 1): 8-13.
Matsumoto S, Tsuji K, Shirahama S. Rebamipide enema therapy for left-sided ischemic colitis patients accompanied by ulcers: Open label study. World J Gastroenterol, 2008 July 7, 14(25): 4059-4064.
Zhang Sh, Qing Q, Bai Y. Rebamipide Helps Defend Against Nonsteroidal Anti- Inflammatory Drugs Induced Gastroenteropathy: A Systematic Review and Meta-Analysis. Dig. Dis. Sci., 2013, 58: 1991-2000.
Fujiwara Sh, Morita Y, Toyonaga T. A randomized controlled trial of rebamipide plus rabeprazole for the healing of artificial ulcers after endoscopic submucosal dissection. J Gastroenterol, 2011, 46: 595-602.
Fujimori Sh, Gudis K and Sakamoto Ch. A Review of Anti-Inflammatory Drug-Induced Gastrointestinal Injury: Focus on Prevention of Small Intestinal Injury. Pharmaceuticals, 2010, 3: 1187-1201.
Soo Heon Park, Chul Soo Cho. Comparison of Prevention of NSAID-Induces Gastrointestinal Complications by Rebamipide and Misoprostol: A randomised, multicenter, Controlled Trial-STORM STUDY. J. Clin Biochem. Nutr., 2007 March, 40: 148-155.
YiqiDu Zhaoshen, Li Xianbao Zhan. Antiinflammatory Effects of Rebamipide According to Helicobacter pylori Status in Patients with Chronic Erosive Gastritis: A Randomized Sucralfate-Controlled Multicenter Trial in China-STARS Study. Dig. Dis. Sci., 2008, 53: 2886- 2895.
Еремина.Е.Ю. Новые возможности цитопротективной терапии эрозивно-язвенных поражений желудочно-кишечного тракта. Практическая гастроэнтерология, 2015, 16: 1-4.
Клинические рекомендации по диагностике и лечению эрозивно-язвенных поражений желудка и двенадцатиперстной кишки, вызванных нестероидными противовоспалительными препаратами. Российская Гастро энтерологическая Ассоциация. Доступно по http://www.gastro.ru. Ссылка активна на 10.09.2015.http://www.gastro.ru
Клинические рекомендации по применению НПВП. Под ред. А.Е. Каратаева. М.: Има Пресс, 2009.
Симаненков В.И., Тихонов С.В. Ребамипид – новые возможности гастропротекции. Терапевтический архив, 2015, 12 115-117.
Ткач С.М., Балабанцева А.П. Современные подходы к лечению НПВП-энтеропатий. Гастроэнтерология, 2014, 6(80): 37-42.
Каратеев А.Е., Яхно Н.Н., Лазебник Л.Б., Кукушкин М.Л., Дроздов В.Н., Исаков В.А. Применение нестероидных противовоспалительных препаратов. М.: ИмаПРЕСС, 2009.